7Baggers
 lexicon awaits fda feedback on diabetes drug application in q4 by investing.com  Investing.com Nigeria Tue, 23 Sep 2025 08:53:40 GMT
 lexicon pharmaceuticals (lxrx) faces fda review extension for zy  GuruFocus Mon, 22 Sep 2025 21:13:24 GMT
 lexicon (lxrx) seeks fda feedback on zynquista with new data sub  GuruFocus Mon, 22 Sep 2025 20:45:46 GMT
 fda pushes back review of lexicon diabetes drug data  富途牛牛 Mon, 22 Sep 2025 20:26:00 GMT
 lexicon submits additional data for its diabetes drug to us fda  TradingView Mon, 22 Sep 2025 20:10:16 GMT
 Lexicon reports FDA's decision to extend review period for Zynquista  Seeking Alpha Mon, 22 Sep 2025 07:00:00 GMT
 lexicon awaits fda feedback on diabetes drug application in q4  Investing.com Mon, 22 Sep 2025 07:00:00 GMT
 Lexicon Pharmaceuticals (LXRX) Highlights Promising Phase 2b Stu  GuruFocus Wed, 17 Sep 2025 07:00:00 GMT
 Lexicon Pharmaceuticals jumps amid takeover speculation  MSN Tue, 16 Sep 2025 23:31:29 GMT
 published on: 2025-09-16 15:08:33  خودرو بانک Tue, 16 Sep 2025 11:41:28 GMT
 Lexicon Pharmaceuticals stock maintains Buy rating at H.C. Wainwright  Investing.com Thu, 11 Sep 2025 07:00:00 GMT
 lexicon submits additional data to fda for zynquista diabetes drug  StreetInsider Mon, 08 Sep 2025 12:31:41 GMT
 Lexicon Pharmaceuticals at H.C. Wainwright: Strategic Program Updates  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 lexicon submits new data to fda for potential diabetes drug approval  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 why lexicon pharmaceuticals' shares popped  AOL.com Mon, 08 Sep 2025 00:22:42 GMT
 lexicon at citi’s biopharma conference: strategic pipeline insights  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-08-28 22:50:55  Newser Fri, 29 Aug 2025 03:50:55 GMT
 published on: 2025-08-27 13:23:22  Newser Wed, 27 Aug 2025 18:23:22 GMT
 published on: 2025-08-25 03:06:26  Newser Mon, 25 Aug 2025 08:06:26 GMT

Lexicon Pharmaceuticals, Inc
(NASDAQ:LXRX) 

LXRX stock logo

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the t...

Founded: 1995
Full Time Employees: 184
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends